BAC vs SLS Stock Comparison

BAC currently leads SLS in this stock comparison, with AIQ scores of 58 vs 57. The clearest difference is risk resilience, while SLS has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
BAC
Financial Services
vs
SLS
Healthcare
BAC
Bank of America Corporation
Leads
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
SLS
SELLAS Life Sciences Group, Inc.
Price
$7.86
Day move
-2.12%
AIQ Score
57/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and SLS?

BAC leads the current stock comparison as Bank of America Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs SELLAS Life Sciences Group, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 61/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

BAC leads

BAC leads by 1 AIQ points, primarily on Risk Resilience, having only recently taken the lead back from SLS.

Fragile: 3 of 4 evidence groups support BAC, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 4Comparison trend: Reversed
BAC

Bank of America Corporation

Leads
AIQ Score
58/100
AIQ Edge Score
6/10
SLS

SELLAS Life Sciences Group, Inc.

AIQ Score
57/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors BAC over SLS, 58 versus 57 as of Nov 15, 2026. BAC's advantage is driven primarily by stronger risk resilience, while SLS holds the stronger momentum profile. BAC also shows the stronger technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor BAC today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. BAC lead: Reversed — SLS led by 7 AIQ points 30 sessions ago; BAC now leads by 1.

Compare Bank of America Corporation and SELLAS Life Sciences Group, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+24.0%
SLS
+11.2%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,399 · SLS $11,117

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and SLS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
SLS advantage
  • Risk Resilience83 vs 32
    BAC +51
  • Momentum37 vs 55
    SLS +18
  • Quality64 vs 73
    SLS +9

3 of 4 evidence groups favor BAC. BAC’s edge is concentrated in risk resilience; SLS keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
SLS0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Distribution Pattern — bearish, volume, medium horizon (1.48x)

BAC's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and SLS both carry a full feed there.

The central trade-off

BAC (Bank of America Corporation): the stronger current systematic profile, led by risk resilience.

SLS (SELLAS Life Sciences Group, Inc.): the counter-case, on momentum, quality — but at materially higher volatility, 114.5% against 24.8%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BAC

BAC on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

SLS

SLS on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

SLS

SLS on the Momentum factor, by 18 points.

Lower downside

BAC

BAC on Risk Resilience, by 51 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBACSLSNote
Implied upside to target+24.1%—Level
Target dispersion+25.3%—Lower is tighter analyst agreement
ConsensusBuyStrong BuyContext, not a primary driver
Analysts covering252Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor BAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven58 vs 57
FundamentalsBACTTM ROE 2.3% vs -7.7%
ValuationNot coveredNot covered
TechnicalsBACPrice vs 50-day -5.6% vs -28.7%; vs 200-day -7% vs -10.5%
Risk ResilienceBACRisk Resilience 83 vs 32
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and SLS and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BAC.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BAC lead: Reversed — SLS led by 7 AIQ points 30 sessions ago; BAC now leads by 1.

May 27BAC leads above the line · SLS leads belowNov 13
Today
BAC +1
58 vs 57
7 sessions ago
SLS +7
58 vs 65
30 sessions ago
SLS +7
62 vs 69
90 sessions ago
SLS +5
71 vs 76

The lead changed hands once in this window, most recently on Nov 12 when BAC moved ahead of SLS.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
SLSConflicted

1 bullish / 2 bearish / 1 neutral, conflicted

Only SLS

  • Golden Cross Active — bullish, trend, long horizon (25.60%)
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (12.28%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.48x)

BAC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

SLSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.12%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1SLS closes the Risk Resilience gap — currently 51 points behind, the largest single contributor to BAC's edge.
  2. 2SLS's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

BAC leads on balance
MetricBACSLS
Revenue growth (YoY)-3.3%0%
EPS growth (YoY)-23.8%0%
Gross margin60.4%0%
Operating margin22.4%0%
Return on equity (TTM)2.3%-7.7%
Debt to equity1.280

Performance

Split across windows
MetricBACSLS
1 week (5 sessions)3.2%-6.7%
1 month (20 sessions)-0.4%-21.2%
3 months (63 sessions)-20.1%-39.5%
6 months (126 sessions)2.5%11%
Year to date-7.2%108.5%
1 year (252 sessions)-5.7%427.5%

Technicals

BAC has the stronger structure
MetricBACSLS
RSI (14)45.934.7
ADX (14)27.225.3
Price vs 50-day-5.6%-28.7%
Price vs 200-day-7%-10.5%
Volatility (1M, annualized)24.8%114.5%

Risk

BAC is the more resilient
MetricBACSLS
Beta0.792.27
Sharpe ratio-0.222.04
Sortino ratio-0.293.43
Max drawdown-23.7%-49.2%
Current drawdown-21.3%-49.2%
Annualized volatility22.4%109.9%
Value at risk (95%)-2.6%-8.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or SLS?

On the Algovestiq AIQ Score, BAC is the stronger of the two as of Nov 15, 2026, scoring 58 against SLS's 57. The edge comes from risk resilience. SLS is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or SLS the better buy right now?

BAC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor BAC over SLS?

The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Risk Resilience by 51 points; SLS leads Momentum by 18 points; SLS leads Quality by 9 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or SLS?

Analyst price targets imply +24.1% upside for BAC and not covered for SLS. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or SLS?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or SLS?

SLS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or SLS?

SLS on the Momentum factor, by 18 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or SLS?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 51 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than SLS?

BAC leads on the comparable margin measures — gross margin 60.4% vs 0%; operating margin 22.4% vs 0%; ttm roe 2.3% vs -7.7%.

Is BAC's lead over SLS getting stronger or weaker?

BAC lead: Reversed — SLS led by 7 AIQ points 30 sessions ago; BAC now leads by 1. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-11-12, when BAC moved ahead of SLS.

What would change the BAC vs SLS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: SLS closes the Risk Resilience gap — currently 51 points behind, the largest single contributor to BAC's edge; SLS's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BAC and SLS?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. SLS: 1 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On SLS it is Golden Cross Active (bullish, long horizon).

Compare BAC and SLS with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.